April 24, 2010 (FinancialWire) — Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT) (TSX Venture: NTB) and Acasti Pharma have expanded Acasti's scientific advisory board with Dr. William S. Harris, PhD, who is joining the current members Pr S Nissen, Pr Thomas G. Hartman, Dr. Magdy M. Abdel-Malik.

Dr. Harris, an expert on omega-3 fatty acids, is a PhD in nutritional biochemistry, research professor, senior scientist and director at the Cardiovascular Health Research Center. Over the last 30 years, Dr. Harris has published over 180 scientific articles on omega-3s, including his revolutionary work which first proposed the Omega-3 Index as a cardiovascular risk factor.

Neptune innovates products for the nutraceutical and pharmaceutical markets.

Streaming Research for all companies mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate, courtesy of Stock Smart (at http://investrend.stocksmart.com/ss/html/hpcompany.html).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

[frlylrf] [biomedphrm] [clvloy]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.